Hangzhou Protobiology Technology

Hangzhou Protobiology Technology is a biotechnology company specializing in AI-driven protein design and engineering. Founded in 2021 and headquartered in Hangzhou, China, the company leverages deep learning and computational biology to develop novel protein therapeutics and industrial enzymes. Their platform integrates high-throughput experimental validation with advanced algorithms to optimize protein stability, binding affinity, and biological function. Protobiology focuses on creating next-generation biologics for oncology and immunology, aiming to address unmet medical needs through de novo protein design. The company is backed by prominent venture capital firms, reflecting its position in the emerging 'AI for Science' sector.